TLR stimulation initiates a CD39-based autoregulatory mechanism that limits macrophage inflammatory responses

Published

September 12, 2013

Author(s)

John P. Marino, Katharine T. Briggs, Heather Cohen, Katya Ravid, Simon C. Robson, David M. Mosser

Abstract

Sepsis is a highly fatal disease caused by an initial hyperinflammatory response followed by a state of profound immunosuppression. Although it is well appreciated that the initial production of proinflammatory cytokines by macrophages accompanies the onset of sepsis, it remains unclear what causes the transition to an immunosuppressive state. In this study, we reveal that macrophages themselves are key regulators of this transition and that the surface enzyme CD39 plays a critical role in self-limiting the activation process. We demonstrate that Toll-like receptor (TLR)-stimulated macrophages modulate their activation state by increasing the synthesis and secretion of adenosine triphosphate (ATP). This endogenous ATP is paradoxically immunosuppressive due to its rapid catabolism into adenosine by CD39. Macrophages lacking CD39 are unable to transition to a regulatory state and consequently continue to produce inflammatory cytokines. The importance of this transition is demonstrated in a mouse model of sepsis, where small numbers of CD39-deficient macrophages were sufficient to induce lethal endotoxic shock. Thus, these data implicate CD39 as a key "molecular switch" that allows macrophages to self-limit their activation state. We propose that therapeutics targeting the release and hydrolysis of ATP by macrophages may represent new ways to treat inflammatory diseases.

Citation

Blood

Volume

122

Issue

11

Pub Type

Journals

Download Paper

DOI Link

Keywords

Macrophage, TLR, CD39, ATP, adenosine, inflammation

Citation

Marino, J. , Briggs, K. , Cohen, H. , Ravid, K. , Robson, S. and Mosser, D. (2013), TLR stimulation initiates a CD39-based autoregulatory mechanism that limits macrophage inflammatory responses, Blood, [online], https://doi.org/10.1182/blood-2013-04-496216 (Accessed April 18, 2024)